Flyer

International Journal of Drug Development and Research

  • ISSN: 0975-9344
  • Journal h-index: 51
  • Journal CiteScore: 46.50
  • Journal Impact Factor: 26.99
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Euro Pub
  • Google Scholar
  • J-Gate
  • SHERPA ROMEO
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Abstract

Formulation and evaluation of Mucoadhesive Buccal tablets of Valsartan

Anup Kumar Roy, Vinod kumar sm, Syed Jalaluddin Basha, Rabiul Haque, Roopa Karki

buccal tablets of Valsartan using various suitable bioadhesive polymers such as CP 934, HPMC K4M, and Na CMC. A backing layer of ethyl cellulose was used which is impermeable in nature. Six formulations of Valsartan were prepared by direct compression method. The prepared tablets were characterized by swelling studies, % matrix erosion, surface pH, bioadhesive properties, In-vitro drug dissolution and In-vitro diffusion studies. It was found that swelling index was proportional to CP and Na CMC content. As the Na CMC content increases the swelling index also increased. The surface pH of all formulations was found to be satisfactory, and values were in between the range of 5-7 pH, hence no irritation to buccal cavity is assumed. Tablets containing CP: HPMC in the ratio 1:3 has shown maximum percentage of In-vitro drug release as well as In-vivo diffusion through buccal mucosa. The drug release was found to be zero order release. The formulation F3 was considered as the optimized formulation based on satisfactory bioadhesive strength, In-vitro dissolution drug release of 59.69 ± 0.95%, In-vitro drug diffusion of 43.66 ± 0.68% for 8 h.